Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin D. Bunker currently holds 834,931 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin D. Bunker has been a net seller of ZNTL stock. They have purchased $6.3K and sold $20.8M worth of shares.
Kevin D. Bunker's most recent insider trade was on Dec 20, 2023, when they sold 24,158 shares at $0.00 per share.
Kevin D. Bunker serves as Executive at Zentalis Pharmaceuticals, Inc. (ZNTL). They have executed 129 insider transactions totaling $20.8M over their tenure at the company.
Kevin D. Bunker holds the position of Executive at Zentalis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Kevin D. Bunker has shown a selling trading pattern, with $6.3K in total purchases and $20.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin D. Bunker was on May 26, 2023, when they sold $2.4M worth of ZNTL shares. This transaction involved 80,000 shares at $30.02 per share.
Kevin D. Bunker currently owns 834,931 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin D. Bunker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin D. Bunker has 129 Form 4 filings on record as an insider at Zentalis Pharmaceuticals, Inc..
Set alerts for Kevin D. Bunker and 40,000+ other insiders.